Thirteen kinds of over-the-counter pharmaceuticals with small side effects and fast treatment effects became available in retail stores or convenience stores as well as drugstores. This is expected to increase consumers’ options for drug purchases and partially resolve discomfort triggered because drugs were only available in drugstores. Nonetheless, applications that inform the locations of st...

Patients benefit from information on pharmaceuticals and most patients are willing to read patient information leaflets for their pharmaceuticals. However, the quality of written information on pharmaceuticals leaves room for improvement. To mend insufficiencies of patient information leaflets, an alternative approach for provision of information on pharmaceuticals is illustrated. We present th...

Dr. Koran has received research grants from Forest Pharmaceuticals, Pfizer, Eli Lilly, Ortho-McNeil, Somaxon, and Jazz Pharmaceuticals. He has received honoraria from the Forest Pharmaceuticals Speakers Bureau and the Pfizer Speakers Bureau. He has received consultant fees from Cypress Bioscience. Dr. Hanna reports no competing interests. Dr. Hollander has received research grants from the Nati...

Various information on pharmaceuticals is provided to healthcare professionals in order to ensure the safe use of pharmaceuticals. In addition to package inserts that contain information on indication, dosage, and administration, some review reports of new drugs which contain the summary of the results of clinical trials submitted for new drug application and review process as well as manuals f...

This chapter summarizes the current knowledge on the occurrence of common pollutants and pharmaceuticals in hospital effluents. These common pollutants include a myriad of biological, inorganic and organic pollutants. Daily and weekly concentration variability is presented for many of the covered pollutants. Particular attention is given to heavy metals (gadolinium and platinum) and pharmaceuti...